Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Howland Capital Management LLC

Howland Capital Management LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,202 shares of the medical equipment provider’s stock after acquiring an additional 320 shares during the period. Howland Capital Management LLC’s holdings in Intuitive Surgical were worth $2,193,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the third quarter worth $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.9 %

ISRG stock opened at $582.98 on Friday. The company has a market cap of $207.65 billion, a price-to-earnings ratio of 90.95, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a 50-day moving average of $554.85 and a two-hundred day moving average of $513.96.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on ISRG shares. Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Barclays upped their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity

In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,940 shares of company stock valued at $3,333,485 in the last 90 days. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.